LifeStance Health Group, Inc. (LFST) shareholders
Close on Nov 17, 2026Market cap $5.41BP/E 109.0Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Coulter, James G Joint filing with Tpg Gp A, LLC (29.30%), Winkelried Jon (29.30%) | 111,744,614 | 29.30% | 13G (passive) amendment | Mar 31, 2026 |
| Tpg Gp A, LLC Joint filing with Coulter, James G (25.70%), Winkelried, Jon (25.70%) | 98,101,407 | 25.70% | 13G (passive) amendment | Jun 30, 2026 |
| FMR LLC Joint filing with Abigail P. Johnson (15.00%) | 58,467,480 | 15.00% | 13G (passive) amendment | Mar 31, 2026 |
| Abigail P. Johnson Joint filing with FMR LLC (10.10%) | 39,249,054 | 10.10% | 13G (passive) amendment | Oct 31, 2025 |
| BlackRock, Inc. | 38,673,303 | 10.10% | 13G (passive) amendment | Sep 30, 2026 |
| Summit Partners, L.P. | 23,310,115 | 6.10% | 13G (passive) amendment | Jun 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of LFST | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Tpg Gp A, LLC | 111,744,614 | 29.25% | $1.20B | −28,281,943 | 23.93% |
| FMR LLC | 58,252,466 | 15.25% | $623.88M | −433,014 | 0.03% |
| BlackRock, Inc. | 36,348,507 | 9.51% | $389.29M | +18,213,556 | 0.01% |
| Summit Partners L P | 23,310,115 | 6.10% | $249.65M | −5,899,661 | 41.00% |
| Vanguard Portfolio Management LLC | 13,960,892 | 3.65% | $149.52M | +4,278,587 | 0.01% |
| Jennison Associates LLC | 12,077,557 | 3.16% | $129.35M | +1,848,756 | 0.08% |
| Dimensional Fund Advisors LP | 11,427,602 | 2.99% | $122.38M | +1,059,922 | 0.02% |
| Vanguard Capital Management LLC | 9,735,076 | 2.55% | $104.26M | +1,826,917 | 0.00% |
| State Street Corp | 8,228,351 | 2.15% | $88.13M | +4,134,857 | 0.00% |
| UBS Asset Management Americas Inc | 5,947,600 | 1.56% | $63.70M | −144,623 | 0.01% |
| Geode Capital Management, LLC | 5,592,598 | 1.46% | $59.91M | +867,444 | 0.00% |
| Morgan Stanley | 5,021,527 | 1.31% | $53.78M | +1,580,301 | 0.00% |
| Principal Financial Group Inc | 3,996,866 | 1.05% | $42.81M | +919,211 | 0.02% |
| Millennium Management LLC | 3,606,755 | 0.94% | $38.63M | +1,707,706 | 0.01% |
| First Eagle Investment Management, LLC | 3,125,932 | 0.82% | $33.48M | +1,515,466 | 0.03% |
| Nuveen, LLC | 3,061,724 | 0.80% | $32.79M | +850,792 | 0.01% |
| Integral Health Asset Management, LLC | 3,000,000 | 0.79% | $32.13M | −1,300,000 | 1.27% |
| Wellington Management Group Llp | 2,883,371 | 0.75% | $30.88M | New | 0.01% |
| Price T Rowe Associates Inc /Md/ | 2,769,327 | 0.72% | $29.66M | +2,619,678 | 0.00% |
| Northern Trust Corp | 2,137,906 | 0.56% | $22.90M | +603,053 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 287 | 377M | 98.7% | 90 / 116 | 53 / 28 | 64M | 56M |
| Q1 2026 | 229 | 369M | 96.6% | 50 / 91 | 55 / 21 | 55M | 42M |
| Q4 2025 | 205 | 374M | 97.9% | 35 / 92 | 60 / 33 | 38M | 13M |
| Q3 2025 | 210 | 350M | 91.7% | 56 / 77 | 60 / 37 | 35M | 34M |
| Q2 2025 | 194 | 349M | 91.4% | 39 / 74 | 59 / 25 | 20M | 14M |
| Q1 2025 | 181 | 343M | 89.9% | 48 / 75 | 36 / 18 | 24M | 17M |
| Q4 2024 | 153 | 337M | 88.1% | 38 / 61 | 34 / 14 | 22M | 15M |
| Q3 2024 | 130 | 329M | 86.1% | 25 / 57 | 28 / 27 | 26M | 16M |
| Q2 2024 | 133 | 327M | 85.6% | 37 / 49 | 27 / 26 | 26M | 22M |
| Q1 2024 | 124 | 323M | 84.5% | 24 / 48 | 30 / 20 | 14M | 2M |
| Q4 2023 | 120 | 310M | 81.2% | 21 / 37 | 39 / 19 | 18M | 6M |
| Q3 2023 | 119 | 298M | 78.1% | 28 / 50 | 28 / 17 | 11M | 3M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
273 funds held LFST in Q2 2026, 39% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of LFST | Value | % of fund | As of |
|---|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 13,804,992 | 3.61% | $147.85M | 0.13% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 6,740,311 | 1.76% | $72.19M | 0.00% | Jun 30, 2026 |
| Fidelity Small Cap Value Fund | 6,520,537 | 1.71% | $68.34M | 1.25% | Jul 31, 2026 |
| VIP Contrafund Portfolio | 5,917,900 | 1.55% | $63.38M | 0.21% | Jun 30, 2026 |
| Fidelity Small Cap Growth Fund | 5,442,419 | 1.42% | $57.04M | 0.65% | Jul 31, 2026 |
| iShares Russell 2000 ETF | 5,001,816 | 1.31% | $53.57M | 0.06% | Jun 30, 2026 |
| Select Health Care Portfolio | 4,979,400 | 1.30% | $38.39M | 0.66% | May 31, 2026 |
| Vanguard Small-Cap Index Fund | 4,887,606 | 1.28% | $52.35M | 0.03% | Jun 30, 2026 |
| PGIM Jennison Small Company Fund | 4,856,204 | 1.27% | $52.01M | 1.49% | Jun 30, 2026 |
| Fidelity Value Fund | 4,541,298 | 1.19% | $47.59M | 0.45% | Jul 31, 2026 |
| Select Medical Technology and Devices Portfolio | 3,983,500 | 1.04% | $30.71M | 1.03% | May 31, 2026 |
| Strategic Advisers Fidelity U.S. Total Stock Fund | 3,128,150 | 0.82% | $24.12M | 0.01% | May 31, 2026 |
| Vanguard Small-Cap Growth Index Fund | 2,829,522 | 0.74% | $30.30M | 0.06% | Jun 30, 2026 |
| Fidelity Small Cap Growth K6 Fund | 2,712,386 | 0.71% | $28.43M | 0.62% | Jul 31, 2026 |
| Vanguard Extended Market Index Fund | 2,633,368 | 0.69% | $28.20M | 0.03% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| David Bourdon | Chief Executive Officer, Director | 1,248,247 | 0.33% | Sep 24, 2026 |
| Ryan Pardo | See Remarks | 840,381 | 0.22% | Nov 13, 2026 |
| Lisa K. Miller | Chief Operating Officer | 251,904 | 0.07% | Nov 12, 2026 |
| Vukasin Paunovich | Chief Technology Officer | 205,379 | 0.05% | Sep 4, 2026 |
| Ann Varanakis | Chief People Officer | 413,881 | 0.11% | Aug 26, 2026 |
| Ryan McGroarty | See Remarks | 772,235 | 0.20% | Mar 26, 2026 |
| Stephanie Carin Eken | Chief Medical Officer | 115,107 | 0.03% | Mar 9, 2026 |
| Ujjwal Ramtekkar | Chief Medical Officer | 103,916 | 0.03% | Jun 18, 2025 |
| Pablo Pantaleoni | Chief Digital Officer | 1,437,881 | 0.38% | May 19, 2025 |
| Kenneth A. Burdick | Director | 3,642,777 | 0.95% | Nov 16, 2026 |
| Teresa DeLuca | Director | 133,456 | 0.03% | Aug 18, 2026 |
| Safwan Shabab | Director | – | – | Jul 7, 2026 |
| Lori Goltermann | Director | 35,492 | 0.01% | Jul 7, 2026 |
| Sarah Personette | Director | 92,512 | 0.02% | Jul 7, 2026 |
| Thurman Justice | Director | 35,492 | 0.01% | Jul 7, 2026 |
| Robert Bessler | Director | 1,308,051 | 0.34% | Jul 7, 2026 |
| Eric P. Palmer | Director | 89,174 | 0.02% | Jul 7, 2026 |
| Darren M. Black | Director | 23,310,115 | 6.10% | May 14, 2026 |
| Eric Shuey | Director | 961,544 | 0.25% | May 14, 2026 |
| James G. Coulter | 10% owner | 175,284,635 | 45.88% | Nov 16, 2026 |
| Tpg Gp A, Llc | 10% owner | 42,458,592 | 11.11% | Nov 16, 2026 |
| Jon Winkelried | 10% owner | 160,711,618 | 42.06% | Nov 16, 2026 |
| Summit Partners Entrepreneur Advisors Fund II, L.P. | – | – | – | Aug 20, 2025 |
| Summit Partners Growth Equity Fund IX-A, L.P. | – | 48,244,251 | 12.63% | Aug 20, 2025 |
| Summit Partners Growth Equity Fund IX-B, L.P. | – | – | – | Aug 20, 2025 |
| Summit Investors Ge Ix/Vc Iv, Llc | – | 45,734,703 | 11.97% | Aug 20, 2025 |
| Summit Investors Ge Ix/Vc Iv (Uk), L.P. | – | 41,932,358 | 10.98% | Aug 20, 2025 |
| Partners L. P. Summit | 10% owner | 79,259,418 | 20.75% | Aug 20, 2025 |
| Silversmith Partners I GP, LLC | – | 19,541,192 | 5.11% | Aug 20, 2025 |
| Silversmith Capital Partners I-C, L.P. | – | 14,324,197 | 3.75% | Aug 20, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Kenneth A. Burdick Director | Nov 12, 2026 | Tax withholding | −2,148,328 | $14.31 | $30.74M | 3,596,266 |
| Kenneth A. Burdick Director | Nov 12, 2026 | Option exercise | +2,999,997 | $7.61 | $22.83M | 5,744,594 |
| Kenneth A. Burdick Director | Nov 12, 2026 | Sale | −159,624 | $14.31 | $2.28M | 2,774,597 |
| Tpg Gp A, Llc 10% owner | Nov 12, 2026 | Sale | −37,233,110 | $13.02 | $484.78M | 42,458,592 |
| Lisa K. Miller Chief Operating Officer | Nov 11, 2026 | Sale(10b5-1 plan) | −14,663 | $14.68 | $215.25K | 251,904 |
| Ryan Pardo See Remarks | Nov 10, 2026 | Sale(10b5-1 plan) | −2,216,585 | $14.58 | $32.32M | 334,935 |
| Ryan Pardo See Remarks | Nov 10, 2026 | Sale(10b5-1 plan) | −587,920 | $14.58 | $8.57M | 505,446 |
| Lisa K. Miller Chief Operating Officer | Nov 10, 2026 | Tax withholding | −14,722 | $14.56 | $214.35K | 266,567 |
| Kenneth A. Burdick Director | Nov 10, 2026 | Sale | −75,000 | $14.60 | $1.10M | 2,904,221 |
| Kenneth A. Burdick Director | Nov 10, 2026 | Option exercise | +75,000 | $7.61 | $570.75K | 2,979,221 |
| Kenneth A. Burdick Director | Nov 9, 2026 | Sale | −66,589 | $14.41 | $959.55K | 2,904,221 |
| David Bourdon Chief Executive Officer, Director | Sep 22, 2026 | Gift | −150,000 | – | – | 948,247 |
| David Bourdon Chief Executive Officer, Director | Sep 22, 2026 | Gift | −150,000 | – | – | 1,098,247 |
| David Bourdon Chief Executive Officer, Director | Sep 22, 2026 | Gift | +150,000 | – | – | 150,000 |
| David Bourdon Chief Executive Officer, Director | Sep 22, 2026 | Gift | +150,000 | – | – | 150,000 |
| Tpg Gp A, Llc 10% owner | Sep 11, 2026 | Sale | −18,409,705 | $12.29 | $226.26M | 79,691,702 |
| David Bourdon Chief Executive Officer, Director | Sep 2, 2026 | Other | −150,000 | – | – | 1,248,247 |
| Vukasin Paunovich Chief Technology Officer | Sep 2, 2026 | Sale | −42,067 | $12.87 | $541.40K | 205,379 |
| Ann Varanakis Chief People Officer | Aug 24, 2026 | Tax withholding | −8,156 | $12.16 | $99.18K | 413,881 |
| Teresa DeLuca Director | Aug 14, 2026 | Sale | −7,500 | $12.68 | $95.10K | 97,093 |
| Teresa DeLuca Director | Aug 13, 2026 | Sale | −20,441 | $12.23 | $249.99K | 104,593 |
| Kenneth A. Burdick Director | Aug 11, 2026 | Sale | −500,000 | $11.51 | $5.76M | 2,970,810 |
| Tpg Gp A, Llc 10% owner | Aug 10, 2026 | Sale | −13,643,207 | $10.62 | $144.89M | 98,101,407 |
| Vukasin Paunovich Chief Technology Officer | Aug 10, 2026 | Sale(10b5-1 plan) | −44,394 | $10.85 | $481.67K | 247,446 |
| Lisa K. Miller Chief Operating Officer | Aug 10, 2026 | Sale(10b5-1 plan) | −47,912 | $10.85 | $519.85K | 281,289 |
| Kenneth A. Burdick Director | Jul 6, 2026 | Award | +45,495 | – | – | 3,470,810 |
| Eric P. Palmer Director | Jul 2, 2026 | Award | +17,746 | – | – | 89,174 |
| Robert Bessler Director | Jul 2, 2026 | Award | +17,746 | – | – | 75,365 |
| Lori Goltermann Director | Jul 2, 2026 | Award | +35,492 | – | – | 35,492 |
| Sarah Personette Director | Jul 2, 2026 | Award | +17,746 | – | – | 92,512 |
| Teresa DeLuca Director | Jul 2, 2026 | Award | +17,746 | – | – | 125,034 |
| Thurman Justice Director | Jul 2, 2026 | Award | +35,492 | – | – | 35,492 |
| Robert Bessler Director | Jun 26, 2026 | Sale(10b5-1 plan) | −447,168 | $10.13 | $4.53M | 539,763 |
| Robert Bessler Director | Jun 26, 2026 | Sale(10b5-1 plan) | −447,169 | $10.13 | $4.53M | 656,560 |
| Vukasin Paunovich Chief Technology Officer | Jun 11, 2026 | Tax withholding | −17,456 | $8.61 | $150.30K | 291,840 |
| Robert Bessler Director | May 12, 2026 | Sale | −287,517 | $8.02 | $2.31M | 986,931 |
| Robert Bessler Director | May 12, 2026 | Sale | −287,517 | $8.02 | $2.31M | 1,103,729 |
| Eric Shuey Director | May 12, 2026 | Sale | −243,362 | $8.02 | $1.95M | 867,562 |
| Tpg Gp A, Llc 10% owner | May 12, 2026 | Sale | −28,281,943 | $8.02 | $226.82M | 111,744,614 |
| Darren M. Black Director | May 12, 2026 | Sale | −5,899,661 | $8.02 | $47.32M | 23,310,115 |
| Robert Bessler Director | May 7, 2026 | Sale(10b5-1 plan) | −37,500 | $8.55 | $320.63K | 1,236,948 |
| Robert Bessler Director | May 7, 2026 | Sale(10b5-1 plan) | −37,500 | $8.55 | $320.63K | 1,353,746 |
| Robert Bessler Director | Apr 24, 2026 | Sale(10b5-1 plan) | −31,074 | $7.05 | $219.07K | 1,391,246 |
| Robert Bessler Director | Apr 24, 2026 | Sale(10b5-1 plan) | −31,073 | $7.05 | $219.06K | 1,274,448 |
| Robert Bessler Director | Apr 23, 2026 | Sale(10b5-1 plan) | −3,876 | $7.00 | $27.13K | 1,305,521 |
| Robert Bessler Director | Apr 23, 2026 | Sale(10b5-1 plan) | −3,876 | $7.00 | $27.13K | 1,422,320 |
| Robert Bessler Director | Apr 21, 2026 | Sale(10b5-1 plan) | −2,550 | $7.01 | $17.88K | 1,426,196 |
| Robert Bessler Director | Apr 21, 2026 | Sale(10b5-1 plan) | −2,551 | $7.01 | $17.88K | 1,309,397 |
| Ryan Pardo See Remarks, Director | Apr 1, 2026 | Tax withholding | −9,376 | $6.37 | $59.73K | 1,093,366 |
| Ryan McGroarty See Remarks | Mar 24, 2026 | Tax withholding | −24,255 | $6.45 | $156.44K | 772,235 |
| Ryan McGroarty See Remarks | Mar 17, 2026 | Tax withholding | −47,594 | $6.89 | $327.92K | 796,490 |
| Vukasin Paunovich Chief Technology Officer | Mar 9, 2026 | Award | +62,935 | – | – | 327,837 |
| Vukasin Paunovich Chief Technology Officer | Mar 9, 2026 | Tax withholding | −18,541 | $6.91 | $128.12K | 309,296 |
| David Bourdon Chief Executive Officer, Director | Mar 9, 2026 | Award | +122,994 | – | – | 1,330,195 |
| David Bourdon Chief Executive Officer, Director | Mar 9, 2026 | Tax withholding | −10,884 | $6.91 | $75.21K | 1,207,201 |
| David Bourdon Chief Executive Officer, Director | Mar 9, 2026 | Tax withholding | −51,474 | $6.91 | $355.69K | 1,278,721 |
| David Bourdon Chief Executive Officer, Director | Mar 9, 2026 | Award | +205,550 | – | – | 1,484,271 |
| David Bourdon Chief Executive Officer, Director | Mar 9, 2026 | Tax withholding | −86,024 | $6.91 | $594.43K | 1,398,247 |
| Ryan Pardo See Remarks, Director | Mar 9, 2026 | Tax withholding | −15,841 | $6.91 | $109.46K | 1,035,510 |
| Ryan Pardo See Remarks, Director | Mar 9, 2026 | Tax withholding | −38,479 | $6.91 | $265.89K | 1,102,742 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of LifeStance Health's stock actually held short. Settlement fails (shares not delivered on time) peaked at 167,373 shares on Sep 16, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Ryan Pardo OFFICER | Nov 10, 2026 | 587,920 | $8.47M | Nov 10, 2026 | COMPENSATION |
| Kimberly Pardo INVESTOR | Nov 10, 2026 | 2,216,585 | $31.92M | Nov 10, 2026 | PRIVATE PLACEEMENT |
| Kenneth A. Burdick Director | Nov 10, 2026 | 75,000 | $1.10M | Nov 10, 2026 | Stock Option Exercise |
| Kenneth A. Burdick Director | Nov 9, 2026 | 66,589 | $959.72K | Nov 9, 2026 | Restricted Stock Vesting |
| Vukasin Paunovich Officer | Sep 2, 2026 | 42,067 | $541.24K | Sep 2, 2026 | Restricted Stock Vesting |
| Teresa DeLuca Director | Aug 14, 2026 | 7,500 | $95.12K | Aug 14, 2026 | Restricted Stock Vesting |
| Teresa DeLuca Director | Aug 13, 2026 | 20,441 | $249.99K | Aug 13, 2026 | Restricted Stock Vesting |
| Kenneth A. Burdick Director | Aug 11, 2026 | 500,000 | $5.76M | Aug 11, 2026 | Restricted Stock Vesting |
| Vukasin Paunovich Officer | Aug 10, 2026 | 44,394 | $481.67K | Aug 10, 2026 | Restricted Stock Vesting |
| Lisa K. Miller Officer | Aug 10, 2026 | 47,912 | $519.85K | Aug 10, 2026 | Restricted Stock Vesting |
| Summit Investors Ge Ix/Vc Iv (Uk), L.P. Owner | Aug 10, 2026 | 1,273 | $13.52K | Aug 10, 2026 | Pre-IPO Transactions |
| Summit Investors Ge Ix/Vc Iv, Llc Owner | Aug 10, 2026 | 12,165 | $129.19K | Aug 10, 2026 | Pre-IPO Transactions |
| Summit Partners Entrepreneur Advisors Fund II, L.P. Owner | Aug 10, 2026 | 1,626 | $17.27K | Aug 10, 2026 | Pre-IPO Transactions |
| Summit Partners Growth Equity Fund IX-A, L.P. Owner | Aug 10, 2026 | 1,088,162 | $11.56M | Aug 10, 2026 | Pre-IPO Transactions |
| Summit Partners Growth Equity Fund IX-A, L.P. Owner | Aug 10, 2026 | 1,742,770 | $18.51M | Aug 10, 2026 | Pre-IPO Transactions |
See a number that looks wrong?